9/17 Department of Pathology and Laboratory Medicine Seminar

“Peptide-based Stx Neutralizers for Treatment of STEC Infections”

Dr. Kiyotaka Nishikawa
Professor, Faculty of Life and Medical Sciences
Doshisha University, Kyoto, Japan

• Thursday, Sept. 17
• 1-2 p.m.
• 670 Albany St., Lobby Level Room 107/108

This event is open to BUMC faculty, students, residents.

At the conclusion of this activity participants will be able to: 1) state that Shiga toxin-producing Escherichia coli causes a spectrum of disease, ranging from asymptomatic carriage (rare) to diarrhea, bloody diarrhea, and the hemolytic uremic syndrome (HUS); 2) recall that HUS, which is a microangiopathic hemolytic anemia with thrombocytopenia and renal failure, is frequently life-threatening and a medical emergency; and 3) identify that there are no specific treatments for these illnesses.

Course Director: Barbara Slack, PhD

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Questions? Call 617-414-7914